Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021,MMWR Morbidity and Mortality Weekly Report

当前位置： X-MOL 学术 › MMWR Morbidity and Mortality Weekly Report › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
MMWR Morbidity and Mortality Weekly Report Pub Date : 2021-08-10 , DOI: 10.15585/mmwr.mm7032e4
Hannah G. Rosenblum , Stephen C. Hadler , Danielle Moulia , Tom T. Shimabukuro , John R. Su , Naomi K. Tepper , Kevin C. Ess , Emily Jane Woo , Adamma Mba-Jonas , Meghna Alimchandani , Narayan Nair , Nicola P. Klein , Kayla E. Hanson , Lauri E. Markowitz , Melinda Wharton , Veronica V. McNally , José R. Romero , H. Keipp Talbot , Grace M. Lee , Matthew F. Daley , Sarah A. Mbaeyi , Sara E. Oliver

中文翻译：